Ca2+/卡尔莫杜林依赖激酶IIδC诱导的慢性心力衰竭不依赖于质网膜Ca2+泄漏
Matthias Dewenter1,2,3, Tilmann Seitz3,4, Julia H Steinbrecher3,4
1Medical Faculty Heidelberg, Institute of Experimental Cardiology, Heidelberg University, Heidelberg, Germany.
ESC heart failure
|April 15, 2024
概括
卡2+/卡尔莫杜林依赖蛋白激酶II (CaMKII) 的过活导致心力衰竭. 阻止CaMKII依赖的氨酸受体2 (RyR2) 酸化阻止泄漏,但不是心力衰竭,这表明其他机制参与其中.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 心脏衰竭病理生理学 病理生理学
背景情况:
- 卡2+/卡尔莫杜林依赖蛋白激酶II (CaMKII) 过活是心力衰竭中病态心脏重塑的关键驱动因素.
- 由CaMKII诱导的氨酸受体2 (RyR2) 的过酸化导致质网膜 (SR) Ca2+泄漏的增加是CaMKII驱动的收缩功能障碍的一个拟议机制.
研究的目的:
- 调查CaMKII-依赖的RyR2酸化在CaMKII诱导的心力衰竭的发展中的体内相关性.
- 为了确定防止RyR2酸化在血清2814 (S2814) 中是否能减轻CaMKII诱导的心脏功能障碍和死亡率.
主要方法:
- 过度表达CaMKIIδC (TG) 的小鼠与抗CaMKII-依赖酸化的RyR2-S2814A敲进小鼠进行杂交.
- 在隔离的腹腔肌细胞中测量Ca2+火花,以评估SR Ca2+泄漏.
- 在转基因小鼠模型中评估心脏功能 (射出分数),心脏缩和存活率.
主要成果:
- 过度表达CaMKIIδC导致显著的SR Ca2+泄漏,而RyR2-S2814A突变完全阻止了这种泄漏.
- 尽管阻止了SR Ca2+泄漏,但RyR2-S2814A突变并没有拯救CaMKIIδC TG小鼠的严重收缩功能障碍,心脏缩或过早死亡.
- 其他CaMKII标,包括基因组脱乙酶4和病理基因标记物 (Xirp2,Il6,Col1a1),在具有RyR2-S2814A突变的小鼠中保持上调,无论SR Ca2+泄漏情况如何.
结论:
- RyR2 S2814的电阻有效地阻断了CaMKII-依赖的SR Ca2+泄漏,但没有阻止由增强的CaMKIIδC活性引起的心肌病现型.
- 这些发现强调,独立于SR Ca2+泄漏的机制对于慢性CaMKIIδC过活性的心力衰竭发展的有害影响至关重要.
相关概念视频
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Feedback Regulation of Calcium Concentration
3.4K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.4K
Smooth Muscle Contraction
2.9K
Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
2.9K
Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422


